53 related articles for article (PubMed ID: 18563491)
1. Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells.
Greenblatt DY; Cayo M; Ning L; Jaskula-Sztul R; Haymart M; Kunnimalaiyaan M; Chen H
J Gastrointest Surg; 2007 Nov; 11(11):1515-20; discussion 1520. PubMed ID: 17874277
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cells.
Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
Surgery; 2008 Dec; 144(6):956-61; discussion 961-2. PubMed ID: 19041003
[TBL] [Abstract][Full Text] [Related]
3. Faulty Metabolism: A Potential Instigator of an Aggressive Phenotype in Cdk5-dependent Medullary Thyroid Carcinoma.
Gupta P; Herring B; Kumar N; Telange R; Garcia-Buntley SS; Caceres TW; Colantonio S; Williams F; Kurup P; Carter AM; Lin D; Chen H; Rose B; Jaskula-Sztul R; Mukhtar S; Reddy S; Bibb JA
bioRxiv; 2023 Jun; ():. PubMed ID: 37398342
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Anticancer Potential of New Hydroxamic Acid Derivatives as Chemotherapeutic Agents.
Korkmaz IN; Özdemir H
Appl Biochem Biotechnol; 2022 Dec; 194(12):6349-6366. PubMed ID: 35917102
[TBL] [Abstract][Full Text] [Related]
5. High-Throughput Analysis to Identify Activators of Notch Signaling.
Guenter R; Eide J; Chen H; Rose JB; Jaskula-Sztul R
Methods Mol Biol; 2022; 2472():49-56. PubMed ID: 35674891
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth
Jang S; Janssen A; Aburjania Z; Robers MB; Harrison A; Dammalapati A; Cheng YQ; Chen H; Jaskula-Sztul R
Oncotarget; 2017 Sep; 8(41):70828-70840. PubMed ID: 29050323
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.
Jang S; Jin H; Roy M; Ma AL; Gong S; Jaskula-Sztul R; Chen H
Cancer Med; 2017 Sep; 6(9):2142-2152. PubMed ID: 28776955
[TBL] [Abstract][Full Text] [Related]
8. Notch-1 Confers Chemoresistance in Lung Adenocarcinoma to Taxanes through AP-1/microRNA-451 Mediated Regulation of MDR-1.
Huang J; Chen Y; Li J; Zhang K; Chen J; Chen D; Feng B; Song H; Feng J; Wang R; Chen L
Mol Ther Nucleic Acids; 2016 Oct; 5(10):e375. PubMed ID: 27727250
[TBL] [Abstract][Full Text] [Related]
9. Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy.
Jaskula-Sztul R; Xu W; Chen G; Harrison A; Dammalapati A; Nair R; Cheng Y; Gong S; Chen H
Biomaterials; 2016 Jun; 91():1-10. PubMed ID: 26994874
[TBL] [Abstract][Full Text] [Related]
10. Notch1 Signaling Regulates the Aggressiveness of Differentiated Thyroid Cancer and Inhibits SERPINE1 Expression.
Yu XM; Jaskula-Sztul R; Georgen MR; Aburjania Z; Somnay YR; Leverson G; Sippel RS; Lloyd RV; Johnson BP; Chen H
Clin Cancer Res; 2016 Jul; 22(14):3582-92. PubMed ID: 26847059
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of NDRG2 Increases Iodine Uptake and Inhibits Thyroid Carcinoma Cell Growth In Situ and In Vivo.
Yin A; Wang C; Sun J; Gao J; Tao L; Du X; Zhao H; Yang J; Li Y
Oncol Res; 2016 Jan; 23(1-2):43-51. PubMed ID: 26802650
[TBL] [Abstract][Full Text] [Related]
12. Suberoyl bis-hydroxamic acid enhances cytotoxicity induced by proteasome inhibitors in breast cancer cells.
Yang X; Shi Z; Zhang N; Ou Z; Fu S; Hu X; Shen Z
Cancer Cell Int; 2014; 14():107. PubMed ID: 25729327
[TBL] [Abstract][Full Text] [Related]
13. Expression of the active Notch1 decreases MTC tumor growth in vivo.
Jaskula-Sztul R; Pisarnturakit P; Landowski M; Chen H; Kunnimalaiyaan M
J Surg Res; 2011 Nov; 171(1):23-7. PubMed ID: 21571316
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer.
Truong M; Cook MR; Pinchot SN; Kunnimalaiyaan M; Chen H
Ann Surg Oncol; 2011 May; 18(5):1506-11. PubMed ID: 21184191
[TBL] [Abstract][Full Text] [Related]
15. The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.
Chen H; Sippel RS; O'Dorisio MS; Vinik AI; Lloyd RV; Pacak K;
Pancreas; 2010 Aug; 39(6):775-83. PubMed ID: 20664475
[TBL] [Abstract][Full Text] [Related]
16. Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.
Cook M; Yu XM; Chen H
Am J Transl Res; 2010 Feb; 2(1):119-25. PubMed ID: 20182588
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma.
Ning L; Wentworth L; Chen H; Weber SM
Am J Transl Res; 2009 Jul; 1(4):358-66. PubMed ID: 19956448
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.
Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
J Surg Res; 2010 Apr; 159(2):640-4. PubMed ID: 19394967
[TBL] [Abstract][Full Text] [Related]
19. Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.
Ning L; Jaskula-Sztul R; Kunnimalaiyaan M; Chen H
Ann Surg Oncol; 2008 Sep; 15(9):2600-5. PubMed ID: 18563491
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
